In the present review, we summarize the recent progress and understanding of CD24 and CD200 as emerging immune checkpoint signals in cancer as well as their interaction with their cognate receptors, sialic acid-binding immunoglobulin (Ig)-like lectin 10 (Siglec-10) and CD200 receptor (CD200R). The gene discussed is CD200R1; the disease is cancer.